Park West Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $18.8M | Sell |
|
|||||
|
2020
Q4 | $36.9M | Buy |
|
|||||
|
2020
Q3 | $27M | Sell |
|
|||||
|
2020
Q2 | $53.7M | Sell |
|
|||||
|
2020
Q1 | $56.8M | Buy |
|
|||||
|
2019
Q4 | $70.4M | Buy |
|
|||||
|
2019
Q3 | $61.8M | Sell |
|
|||||
|
2019
Q2 | $72.4M | Buy |
|
|||||
|
2019
Q1 | $52.8M | Sell |
|
|||||
|
2018
Q4 | $42.3M | Buy |
|
|||||
|
2018
Q3 | $51.4M | Sell |
|
|||||
|
2018
Q2 | $83.5M | Buy |
|
|||||
|
2018
Q1 | $55.4M | Buy |
|
|||||
|
2017
Q4 | $55.4M | Buy |
|
|||||
|
2017
Q3 | $54.2M | Buy |
|
|||||
|
2017
Q2 | $32.1M | Sell |
|
|||||
|
2017
Q1 | $40.5M | Sell |
|
|||||
|
2016
Q4 | $46M | Sell |
|
|||||
|
2016
Q3 | $44.1M | Hold |
|
|||||
|
2016
Q2 | $24.4M | Sell |
|
|||||
|
2016
Q1 | $59.6M | Buy |
|
|||||
|
2015
Q4 | $61.2M | Buy |
|
|||||
|
2015
Q3 | $37.1M | Sell |
|
|||||
|
2015
Q2 | $40.7M | Sell |
|
|||||
|
2015
Q1 | $26.2M | Sell |
|
|||||
|
2014
Q4 | $12.4M | Buy |
|
|||||
|
2014
Q3 | $8.44M | Buy |
|
|||||
|
2014
Q2 | $6.12M | Buy |
|
|||||
|
2014
Q1 | $2.67M | Buy |
|